The transfection technologies market which was USD 1073.22 million in 2022, is expected to reach USD 2001.22 million by 2030, at a CAGR of 8.1% during the forecast period 2023 to 2030.

Transfection Technologies Market Analysis and Size

The market for transfection technologies will expand rapidly due to rising cancer incidences and increased research and development in cell-based therapies. As the prevalence of cancer rises and the number of obese people rises, so the demand for transfection also rises. This factor is propelling the market for transfection technologies. Furthermore, initiatives taken by various government organizations amplify the market's growth.

Get a sample of the report

Data Bridge Market Research analyses that the transfection technologies market which was USD 1073.22 million in 2022, is expected to reach USD 2001.22 million by 2030, at a CAGR of 8.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Transfection Technologies Market Scope

The transfection technologies market is segmented on the basis of transfection method, technology, end-user, and applications. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

  • Application
  • Virus Production
  • Protein Production
  • Gene Silencing
  • Stem Cell Reprogramming and Differentiation
  • Stable Cell Line Generation
  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others
  • Transfection Method
  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others
  • Technology
  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection
  • End-User
  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Academic and research institutes

Transfection Technologies Market Regional Analysis/Insights

The transfection technologies market is analyzed and market size insights and trends are provided by country, transfection method, technology, end-user and applications as referenced above.

The countries covered in the transfection technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Transfection Technologies Market Share Analysis

The transfection technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transfection technologies market.


Some of the major players operating in the transfection technologies market are:


  • Lonza (Switzerland)
  • Promega Corporation (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Roche Molecular Systems, Inc. (U.S.)
  • QIAGEN (Germany)
  • Inovio Pharmaceuticals (U.S.)
  • Polyplus Transfection (France)
  • Mirus Bio LLC (U.S.)
  • Takara Bio Inc. (Japan)
  • SignaGen Laboratories (U.S.)
  • MaxCyte, Inc. (U.S.)
  • Genlantis Inc. (U.S.)
  • Techulon (U.S.)
  • BioAstrum Corporation (U.S.)
  • Altogen Biosystems (U.S.)
  • OZ Biosciences (France)
  • Boca Scientific, Inc. (U.S.)
  • Biontex Laboratories GmbH (Germany)


Get Full Access to the Report



Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insights

Chapter Six: Cranial Implants Treatment Market

Get TOC Details


Browse Related Reports@    

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market



Data Bridge Market Research

Tel: +1-888-387-2818